Gene · 1365
Papers2,896
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,896
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| EMT Features in Claudin-Low versus Claudin-Non-Suppressed Breast Cancers and the Role of Epigenetic Modifications. | Curr Issues Mol Biol | 2023 | 37504297 | PubTator, text mining | PubMed |
| Cinnamaldehyde alleviates zearalenone-induced LS174T cell apoptosis, barrier dysfunction and mucin reduction through JNK/NF-κB signaling pathway. | Ecotoxicol Environ Saf | 2023 | 37499382 | PubTator, text mining | PubMed |
| Identification of inflammatory factor-related genes associated with the prognosis and immune cell infiltration in colorectal cancer patients. | Genes Dis | 2023 | 37492736 | PubTator, text mining | PubMed |
| Roseburia intestinalis generated butyrate boosts anti-PD-1 efficacy in colorectal cancer by activating cytotoxic CD8+ T cells. | Gut | 2023 | 37491158 | PubTator, text mining | PubMed |
| m5C regulator-mediated methylation modification phenotypes characterized by distinct tumor microenvironment immune heterogenicity in colorectal cancer. | Sci Rep | 2023 | 37488178 | PubTator, text mining | PubMed |
| Obesity-associated changes in molecular biology of primary breast cancer. | Nat Commun | 2023 | 37479706 | PubTator, text mining | PubMed |
| How Do Microorganisms Influence the Development of Endometriosis? Participation of Genital, Intestinal and Oral Microbiota in Metabolic Regulation and Immunopathogenesis of Endometriosis. | Int J Mol Sci | 2023 | 37446108 | PubTator, text mining | PubMed |
| Bispecific antibodies targeting EGFR/Notch enhance the response to talazoparib by decreasing tumour-initiating cell frequency. | Theranostics | 2023 | 37441599 | PubTator, text mining | PubMed |
| Twist1‑mediated transcriptional activation of Claudin‑4 promotes cervical cancer cell migration and invasion. | Oncol Lett | 2023 | 37427351 | PubTator, text mining | PubMed |
| Alleviation of Limosilactobacillus reuteri in polycystic ovary syndrome protects against circadian dysrhythmia-induced dyslipidemia via capric acid and GALR1 signaling. | NPJ Biofilms Microbiomes | 2023 | 37422471 | PubTator, text mining | PubMed |
| Identifying high-grade serous ovarian carcinoma-specific extracellular vesicles by polyketone-coated nanowires. | Sci Adv | 2023 | 37418532 | PubTator, text mining | PubMed |
| Administration of Bifidobacterium pseudolongum suppresses the increase of colonic serotonin and alleviates symptoms in dextran sodium sulfate-induced colitis in mice. | Biosci Microbiota Food Health | 2023 | 37404566 | PubTator, text mining | PubMed |
| Dissecting the effect of ileal faecal diversion on the intestine using single-cell sequencing. | Clin Transl Med | 2023 | 37400975 | PubTator, text mining | PubMed |
| Male-Biased Gut Microbiome and Metabolites Aggravate Colorectal Cancer Development. | Adv Sci (Weinh) | 2023 | 37400423 | PubTator, text mining | PubMed |
| Function of Akkermansia muciniphila in type 2 diabetes and related diseases. | Front Microbiol | 2023 | 37396381 | PubTator, text mining | PubMed |
| Alpha-tocopherylquinone differentially modulates claudins to enhance intestinal epithelial tight junction barrier via AhR and Nrf2 pathways. | Cell Rep | 2023 | 37393618 | PubTator, text mining | PubMed |
| Negative consequences of reduced protein diets supplemented with synthetic amino acids for performance, intestinal barrier function, and caecal microbiota composition of broiler chickens. | Anim Nutr | 2023 | 37388459 | PubTator, text mining | PubMed |
| β-Lapachone Exerts Anticancer Effects by Downregulating p53, Lys-Acetylated Proteins, TrkA, p38 MAPK, SOD1, Caspase-2, CD44 and NPM in Oxaliplatin-Resistant HCT116 Colorectal Cancer Cells. | Int J Mol Sci | 2023 | 37373014 | PubTator, text mining | PubMed |
| Integrative single-cell multiomics analyses dissect molecular signatures of intratumoral heterogeneities and differentiation states of human gastric cancer. | Natl Sci Rev | 2023 | 37347037 | PubTator, text mining | PubMed |
| The genomic signature of resistance to platinum-containing neoadjuvant therapy based on single-cell data. | Cell Biosci | 2023 | 37291676 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1365/papers?page=16